Pediatric Bone Marrow Transplant Physician - Section Chief

Thanks for your interest in Children's Mercy!

Do you envision finding a meaningful role with an inclusive and compassionate team? At Children’s Mercy, we believe in making a difference in the lives of all children and shining a light of hope to the patients and families we serve. Our employees make the difference, which is why we have been recognized by U.S. News & World Report as a top pediatric hospital, for eleven consecutive years.

Children’s Mercy is in the heart of Kansas City – a metro abounding in cultural experiences, vibrant communities and thriving businesses. This is where our patients and families live, work and play. This is a community that has embraced our hospital and we strive to say thanks by giving back. As a leader in children’s health, we engage in meaningful programs and partnerships throughout the region so that we can improve the lives of children beyond the walls of our hospital.

The Division of Hematology/Oncology/Bone Marrow Transplantation (BMT) is seekinga pediatric bone marrow transplant specialist to serve as Section Chief of the BMT/cellular therapy program at Children’s Mercy Kansas City. Applicants must possess a medical degree and Board eligibility or certification in Pediatric Hematology/Oncology. The ideal candidate must have several years’ experience in clinical care of pediatric hematopoietic stem cell transplant and immune effector cell therapy and prior academic and clinical-based leadership experience.

In addition, candidates with demonstrated research productivity and commitment to basic/translational immunotherapy focused research will be given preference in consideration.

Responsibilities of this position include clinical leadership for the bone marrow transplant and cellular therapy team and programs, participation in and leadership for clinical and quality improvements, support in faculty career development and the provision of excellent clinical care to patients referred to the BMT/cellular therapy service. Candidates interested in building and/or maintaining a successful basic or translational research program focused on high impact immunotherapy/transplant will receive support to ensure the candidate’s successful pursuit of this goal.

Clinical responsibilities will be within the Section of Bone Marrow Transplant in the Division of Pediatric Hematology/Oncology/BMT and include shared clinic, inpatient, and call responsibilities. Protected time and support for program leadership and translational investigation will be provided by the Department of Pediatrics and the Children’s Mercy Research Institute. The academic appointment will be at the assistant, associate or full professor level commensurate upon a candidate’s qualifications.

A successful candidate for this position will join us as we strive to create a workplace that reflects the community we serve, as well as our core values of kindness, curiosity, inclusion, team and integrity.

Children's Mercy Kanas City has a full-service BMT program with a full complement of staffing including three other faculty physicians, six advanced practice providers, and in-house, overnight coverage by Heme-Onc trained physicians. The program is a FACT-accredited, and National Marrow Donor Program and Children’s Oncology Group designated transplant center. We perform 35-60 transplants annually for a variety of malignant and non-malignant diseases while utilizing all donor sources including haploidentical donors and banked cord blood.

The program is focused on novel, less toxic transplant approaches to treat patients with non-malignant diseases, such as severe combined immunodeficiency, aplastic anemia, hemoglobinopathies and rare genetic disorders. The BMT program has conducted investigator-initiated CAR T-cell trials and participated in industry and cooperative group cell therapy trials. Our institution was one of the first to join the pivotal trial leading to FDA approval of Kymriah and has a faculty member on that study steering committee.

The program has a budding laboratory footprint in the area of cellular therapy for cancer, as well.

Research endeavors will receive support from the Children’s…